Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy

12 Jan 2022

Abstract excerpt

Background. Serine/arginine-rich splicing factor 9 (SRSF9) is one of the members of SRSF gene family and related to the tumorigenesis and the progression of tumor. However, whether SRSF9 has a crucial role across pan-cancer is still unknown. Methods. In this study, we used public databases, such as The Cancer Genome Atlas (TCGA), Cancer Cell Line Encyclopedia (CCLE), and Genotype-Tissue Expression (GTEx), to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35069733
DOI: 10.1155/2022/3477148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and ImmunotherapyPMID 35069733Read ↗

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-CancerSemantic proximity Read ↗

Systematic Investigation of the Multifaceted Role of SOX11 in CancerSemantic proximity Read ↗

Systematic Analysis Of Expression Profiles Of SRSF Family Members For Prognostic Application In DLBCLSemantic proximity Read ↗

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy BiomarkerSemantic proximity Read ↗

Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancerSemantic proximity Read ↗

Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for gliomaSemantic proximity Read ↗

Multi-omics and single-cell analysis reveals TM9SF1 as a biomarker in pan-cancer diagnosis and prognosis, with a special focus on hepatocellular carcinomaSemantic proximity Read ↗

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read ↗

Elucidating the role of cGAS in pan-cancer using integrated bioinformatics and experimental approachesSemantic proximity Read ↗

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read ↗

SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancerSemantic proximity Read ↗

A Multilevel Systemic Pan-cancer Analysis: Collagen Triple Helix Repeat Containing-1 is a Potential Target for Tumor ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.